Skip to main content
. Author manuscript; available in PMC: 2022 Jan 8.
Published in final edited form as: Circ Res. 2017 Sep 18;121(11):1279–1290. doi: 10.1161/CIRCRESAHA.117.311827

Table 4.

Recipient cPRA Change 6 Months Post-TESI

Cell Type
 cPRA Risk 20M (n=15) 100M (n=15)
No reaction to Low risk (0 – 20% cPRA) 1 (6.7%) 0 (0.0%)
Moderate risk (21 – 79% cPRA) 0 (0.0%) 0 (0.0%)
High risk (+80% cPRA) 0 (0.0%) 0 (0.0%)

Values are n (%). cPRA = calculated panel reactive antibodies.